MX2015009045A - Compositions and methods for treating severe pain. - Google Patents

Compositions and methods for treating severe pain.

Info

Publication number
MX2015009045A
MX2015009045A MX2015009045A MX2015009045A MX2015009045A MX 2015009045 A MX2015009045 A MX 2015009045A MX 2015009045 A MX2015009045 A MX 2015009045A MX 2015009045 A MX2015009045 A MX 2015009045A MX 2015009045 A MX2015009045 A MX 2015009045A
Authority
MX
Mexico
Prior art keywords
methods
compositions
severe pain
treating severe
pharmaceutical compositions
Prior art date
Application number
MX2015009045A
Other languages
Spanish (es)
Inventor
John Brew
Robin Mark Bannister
George William Schlich
Original Assignee
Infirst Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Infirst Healthcare Ltd filed Critical Infirst Healthcare Ltd
Publication of MX2015009045A publication Critical patent/MX2015009045A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

The present specification discloses pharmaceutical compositions, methods of preparing such pharmaceutical compositions, and methods and uses of treating a chronic inflammation and/or an inflammatory disease in an individual using such pharmaceutical compositions.
MX2015009045A 2013-01-14 2014-01-14 Compositions and methods for treating severe pain. MX2015009045A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361752356P 2013-01-14 2013-01-14
PCT/EP2014/050628 WO2014108569A1 (en) 2013-01-14 2014-01-14 Compositions and methods for treating severe pain

Publications (1)

Publication Number Publication Date
MX2015009045A true MX2015009045A (en) 2015-12-17

Family

ID=50064547

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015009045A MX2015009045A (en) 2013-01-14 2014-01-14 Compositions and methods for treating severe pain.

Country Status (14)

Country Link
EP (1) EP2943183A1 (en)
JP (1) JP6474732B2 (en)
KR (1) KR20150129665A (en)
CN (1) CN104968330A (en)
AU (1) AU2014204739B2 (en)
BR (1) BR112015015864B1 (en)
CA (1) CA2897874A1 (en)
HK (1) HK1217650A1 (en)
IL (1) IL239921A0 (en)
MX (1) MX2015009045A (en)
RU (1) RU2677346C2 (en)
SG (1) SG11201505245XA (en)
WO (1) WO2014108569A1 (en)
ZA (1) ZA201505005B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9504664B2 (en) 2010-10-29 2016-11-29 Infirst Healthcare Limited Compositions and methods for treating severe pain
US9308213B2 (en) 2010-10-29 2016-04-12 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US9271950B2 (en) 2010-10-29 2016-03-01 Infirst Healthcare Limited Compositions for treating chronic inflammation and inflammatory diseases
US10695432B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US11202831B2 (en) 2010-10-29 2021-12-21 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
US10695431B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
US9744132B2 (en) 2010-10-29 2017-08-29 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US8895536B2 (en) 2010-10-29 2014-11-25 Infirst Healthcare Ltd. Compositions and methods for treating chronic inflammation and inflammatory diseases
US11730709B2 (en) 2010-10-29 2023-08-22 Infirst Healthcare Limited Compositions and methods for treating severe pain
US11224659B2 (en) 2010-10-29 2022-01-18 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US11896037B2 (en) * 2016-08-03 2024-02-13 Temple University-Of The Commonwealth System Of Higher Education Microencapsulation of active agents
JP7027786B2 (en) * 2017-10-12 2022-03-02 ライオン株式会社 Oral treatment for myofascial pain

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5143934A (en) * 1990-11-21 1992-09-01 A/S Dumex (Dumex Ltd.) Method and composition for controlled delivery of biologically active agents
GB9613858D0 (en) * 1996-07-02 1996-09-04 Cortecs Ltd Hydrophobic preparations
CZ297206B6 (en) * 1997-07-29 2006-10-11 Pharmacia & Upjohn Company Pharmaceutical composition and self-emulsifying formulation for lipophilic compounds
HU228923B1 (en) * 1997-07-29 2013-06-28 Upjohn Co Pharmaceutical composition for acidic lipophilic compounds in a form of a self-emulsifying formulation
GB2331458B (en) * 1997-11-21 2002-07-31 Gursharan Singh Moonga Solubilising systems for difficult pharmaceutical actives for preparing concentrated stable solutions for encapsulation into soft gelatine
US6248363B1 (en) 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6267985B1 (en) 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US6294192B1 (en) 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6383471B1 (en) 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
KR20020011985A (en) * 1999-05-07 2002-02-09 파르마솔 게엠베하 Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same
CA2369594A1 (en) * 1999-05-07 2000-11-16 Pharmasol Gmbh Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same
CA2377301C (en) * 1999-06-14 2009-05-12 Cosmo S.P.A. Controlled release and taste masking oral pharmaceutical compositions
US6455067B1 (en) * 2000-05-24 2002-09-24 Sang-A Pharmaceutical Co., Ltd. Transdermal patch for nonsteroidal antiinflammatory drug(s)
JP2002284705A (en) * 2001-01-19 2002-10-03 Shiseido Co Ltd Torpent
GB0402679D0 (en) * 2004-02-06 2004-03-10 Novartis Ag Organic compounds
US20070298099A1 (en) * 2004-11-24 2007-12-27 Peresypkin Andrey V Liquid and Semi-Solid Pharmaceutical Formulations for Oral Administration of a Substituted Amide
AU2006240551A1 (en) * 2005-04-28 2006-11-02 Dsm Ip Assets B.V. Pharmaceutical dosage forms comprising a lipid phase
GB0610867D0 (en) * 2006-06-01 2006-07-12 Syntaxin Ltd Treatment of pain
GB0704846D0 (en) * 2007-03-13 2007-04-18 Futura Medical Dev Ltd Topical pharmaceutical formulation
US8461183B2 (en) 2008-05-26 2013-06-11 Genfit PPAR agonist compounds, preparation and uses
CN102048680B (en) * 2009-11-11 2013-05-01 河北奥星集团药业有限公司 Enteric sustained-release preparation containing zaltoprofen and preparation method thereof
MX346224B (en) * 2011-02-04 2017-03-10 Biocopea Ltd Compostions and methods for treating chronic inflammation and inflammatory diseases.
CN102579350B (en) * 2012-03-02 2013-04-24 海南灵康制药有限公司 Pidotimod liposome solid preparation

Also Published As

Publication number Publication date
KR20150129665A (en) 2015-11-20
ZA201505005B (en) 2016-10-26
CN104968330A (en) 2015-10-07
IL239921A0 (en) 2015-08-31
WO2014108569A1 (en) 2014-07-17
RU2015134136A (en) 2017-02-20
CA2897874A1 (en) 2014-07-17
HK1217650A1 (en) 2017-01-20
SG11201505245XA (en) 2015-08-28
AU2014204739A1 (en) 2015-07-16
RU2677346C2 (en) 2019-01-16
BR112015015864B1 (en) 2022-08-23
AU2014204739B2 (en) 2016-08-11
JP6474732B2 (en) 2019-02-27
BR112015015864A2 (en) 2017-07-11
JP2016504401A (en) 2016-02-12
BR112015015864A8 (en) 2018-01-16
EP2943183A1 (en) 2015-11-18

Similar Documents

Publication Publication Date Title
MX2015009105A (en) Solid solution compositions and use in chronic inflammation.
MX366317B (en) Compositions and methods for treating chronic inflammation and inflammatory diseases.
MX2015009045A (en) Compositions and methods for treating severe pain.
MX2013008851A (en) Compostions and methods for treating chronic inflammation and inflammatory diseases.
MX2020009780A (en) Autotaxin inhibitor compounds.
EP3052476A4 (en) Substituted nicotinimide inhibitors of btk and their preparation and use in the treatment of cancer, inflammation and autoimmune disease
IL283432A (en) Compositions, methods and systems for the treatment of cutaneous disorders
EP3166648A4 (en) Compositions and delivery methods for treating dental infections, inflammation, sensitivity, and for use in dental restorations
ZA201706402B (en) C.novyi for the treatment of solid tumors in humans
PH12016500863A1 (en) Tetracyclic autotaxin inhibitors
TR201910866T4 (en) Combined preparations for cancer treatment.
HK1224184A1 (en) Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases
AU2018253600A1 (en) Dosage forms and therapeutic uses of l-4-chlorokynurenine
WO2014159669A3 (en) Aptamers that bind to il-6 and their use in treating or diagnosing il-6 mediated conditions
WO2014146111A3 (en) Analgesic compounds and methods of use
HK1213810A1 (en) Nsaid administration and related compositions, methods and systems nsaid
MX2015016603A (en) Corticosteroid compositions.
PH12017501979A1 (en) Pharmaceutical compound
PH12020500472A1 (en) Autotaxin inhibitor compounds
IN2013MU03429A (en)
EP2998298A4 (en) Phenylimidazole derivative, and therapeutic medicine or preventive medicine for inflammatory disease, etc.
MX2016010919A (en) 4-benzylsulfonyl-2-butenenitrile.
HUE050771T2 (en) Substituted nicotinimide inhibitors of btk and their preparation and use in the treatment of cancer, inflammation and autoimmune disease
IN2013MU03855A (en)